 | • レポートコード：QYR2104Z4248 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、オリゴヌクレオチド合成のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カスタムオリゴヌクレオチド、プレデザインオリゴヌクレオチド）、用途別市場規模（学術研究機関、製薬＆バイオテクノロジー企業、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・オリゴヌクレオチド合成の市場動向 ・企業の競争状況、市場シェア ・オリゴヌクレオチド合成の種類別市場規模（カスタムオリゴヌクレオチド、プレデザインオリゴヌクレオチド） ・オリゴヌクレオチド合成の用途別市場規模（学術研究機関、製薬＆バイオテクノロジー企業、診断研究所、その他） ・オリゴヌクレオチド合成の北米市場規模2016-2027（アメリカ、カナダ） ・オリゴヌクレオチド合成のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・オリゴヌクレオチド合成のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・オリゴヌクレオチド合成の中南米市場規模2016-2027（メキシコ、ブラジル） ・オリゴヌクレオチド合成の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Integrated DNA Technologies、Merck、Eurofins Genomics、Thermo Fisher Scientific、Agilent Technologies、Eurogentec、GE Healthcare、LGC Biosearch Technologies、Nitto Denko Avecia、Genscript、Genedesign、TriLink Biotechnologies、Bio-Synthesis、ATDBio） ・結論 |
Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
Market Analysis and Insights: Global Oligonucleotide Synthesis Market
The global Oligonucleotide Synthesis market size is projected to reach US$ 2768.9 million by 2026, from US$ 1790.7 million in 2019, at a CAGR of 6.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oligonucleotide Synthesis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oligonucleotide Synthesis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oligonucleotide Synthesis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oligonucleotide Synthesis market.
Global Oligonucleotide Synthesis Scope and Market Size
Oligonucleotide Synthesis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotide Synthesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Custom Oligonucleotides
Pre-designed Oligonucleotides
Segment by End User
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Integrated DNA Technologies
Merck
Eurofins Genomics
Thermo Fisher Scientific
Agilent Technologies
Eurogentec
GE Healthcare
LGC Biosearch Technologies
Nitto Denko Avecia
Thermo Fisher Scientific
Agilent Technologies
TriLink Biotechnologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Custom Oligonucleotides
1.2.3 Pre-designed Oligonucleotides
1.3 Market by Application
1.3.1 Global Oligonucleotide Synthesis Market Share by End User: 2016 VS 2021 VS 2027
1.3.2 Academic Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Synthesis Market Perspective (2016-2027)
2.2 Oligonucleotide Synthesis Growth Trends by Regions
2.2.1 Oligonucleotide Synthesis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oligonucleotide Synthesis Historic Market Share by Regions (2016-2021)
2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Regions (2022-2027)
2.3 Oligonucleotide Synthesis Industry Dynamic
2.3.1 Oligonucleotide Synthesis Market Trends
2.3.2 Oligonucleotide Synthesis Market Drivers
2.3.3 Oligonucleotide Synthesis Market Challenges
2.3.4 Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Oligonucleotide Synthesis Players by Revenue (2016-2021)
3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2016-2021)
3.2 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oligonucleotide Synthesis Revenue
3.4 Global Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2020
3.5 Oligonucleotide Synthesis Key Players Head office and Area Served
3.6 Key Players Oligonucleotide Synthesis Product Solution and Service
3.7 Date of Enter into Oligonucleotide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2016-2021)
4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2022-2027)
5 Oligonucleotide Synthesis Breakdown Data by End User
5.1 Global Oligonucleotide Synthesis Historic Market Size by End User (2016-2021)
5.2 Global Oligonucleotide Synthesis Forecasted Market Size by End User (2022-2027)
6 North America
6.1 North America Oligonucleotide Synthesis Market Size (2016-2027)
6.2 North America Oligonucleotide Synthesis Market Size by Type
6.2.1 North America Oligonucleotide Synthesis Market Size by Type (2016-2021)
6.2.2 North America Oligonucleotide Synthesis Market Size by Type (2022-2027)
6.2.3 North America Oligonucleotide Synthesis Market Size by Type (2016-2027)
6.3 North America Oligonucleotide Synthesis Market Size by End User
6.3.1 North America Oligonucleotide Synthesis Market Size by End User (2016-2021)
6.3.2 North America Oligonucleotide Synthesis Market Size by End User (2022-2027)
6.3.3 North America Oligonucleotide Synthesis Market Size by End User (2016-2027)
6.4 North America Oligonucleotide Synthesis Market Size by Country
6.4.1 North America Oligonucleotide Synthesis Market Size by Country (2016-2021)
6.4.2 North America Oligonucleotide Synthesis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oligonucleotide Synthesis Market Size (2016-2027)
7.2 Europe Oligonucleotide Synthesis Market Size by Type
7.2.1 Europe Oligonucleotide Synthesis Market Size by Type (2016-2021)
7.2.2 Europe Oligonucleotide Synthesis Market Size by Type (2022-2027)
7.2.3 Europe Oligonucleotide Synthesis Market Size by Type (2016-2027)
7.3 Europe Oligonucleotide Synthesis Market Size by End User
7.3.1 Europe Oligonucleotide Synthesis Market Size by End User (2016-2021)
7.3.2 Europe Oligonucleotide Synthesis Market Size by End User (2022-2027)
7.3.3 Europe Oligonucleotide Synthesis Market Size by End User (2016-2027)
7.4 Europe Oligonucleotide Synthesis Market Size by Country
7.4.1 Europe Oligonucleotide Synthesis Market Size by Country (2016-2021)
7.4.2 Europe Oligonucleotide Synthesis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Synthesis Market Size (2016-2027)
8.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Type
8.2.1 Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2016-2027)
8.3 Asia-Pacific Oligonucleotide Synthesis Market Size by End User
8.3.1 Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2016-2021)
8.3.2 Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2022-2027)
8.3.3 Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2016-2027)
8.4 Asia-Pacific Oligonucleotide Synthesis Market Size by Region
8.4.1 Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oligonucleotide Synthesis Market Size (2016-2027)
9.2 Latin America Oligonucleotide Synthesis Market Size by Type
9.2.1 Latin America Oligonucleotide Synthesis Market Size by Type (2016-2021)
9.2.2 Latin America Oligonucleotide Synthesis Market Size by Type (2022-2027)
9.2.3 Latin America Oligonucleotide Synthesis Market Size by Type (2016-2027)
9.3 Latin America Oligonucleotide Synthesis Market Size by End User
9.3.1 Latin America Oligonucleotide Synthesis Market Size by End User (2016-2021)
9.3.2 Latin America Oligonucleotide Synthesis Market Size by End User (2022-2027)
9.3.3 Latin America Oligonucleotide Synthesis Market Size by End User (2016-2027)
9.4 Latin America Oligonucleotide Synthesis Market Size by Country
9.4.1 Latin America Oligonucleotide Synthesis Market Size by Country (2016-2021)
9.4.2 Latin America Oligonucleotide Synthesis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Synthesis Market Size (2016-2027)
10.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Type
10.2.1 Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2016-2027)
10.3 Middle East & Africa Oligonucleotide Synthesis Market Size by End User
10.3.1 Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2016-2021)
10.3.2 Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2022-2027)
10.3.3 Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2016-2027)
10.4 Middle East & Africa Oligonucleotide Synthesis Market Size by Country
10.4.1 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.1.5 Integrated DNA Technologies Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Oligonucleotide Synthesis Introduction
11.2.4 Merck Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Company Details
11.3.2 Eurofins Genomics Business Overview
11.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction
11.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.3.5 Eurofins Genomics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction
11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Oligonucleotide Synthesis Introduction
11.5.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.5.5 Agilent Technologies Recent Development
11.6 Eurogentec
11.6.1 Eurogentec Company Details
11.6.2 Eurogentec Business Overview
11.6.3 Eurogentec Oligonucleotide Synthesis Introduction
11.6.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.6.5 Eurogentec Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Oligonucleotide Synthesis Introduction
11.7.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.7.5 GE Healthcare Recent Development
11.8 LGC Biosearch Technologies
11.8.1 LGC Biosearch Technologies Company Details
11.8.2 LGC Biosearch Technologies Business Overview
11.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction
11.8.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.8.5 LGC Biosearch Technologies Recent Development
11.9 Nitto Denko Avecia
11.9.1 Nitto Denko Avecia Company Details
11.9.2 Nitto Denko Avecia Business Overview
11.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction
11.9.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.9.5 Nitto Denko Avecia Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript Oligonucleotide Synthesis Introduction
11.10.4 Genscript Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.10.5 Genscript Recent Development
11.11 Genedesign
11.11.1 Genedesign Company Details
11.11.2 Genedesign Business Overview
11.11.3 Genedesign Oligonucleotide Synthesis Introduction
11.11.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.11.5 Genedesign Recent Development
11.12 TriLink Biotechnologies
11.12.1 TriLink Biotechnologies Company Details
11.12.2 TriLink Biotechnologies Business Overview
11.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction
11.12.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.12.5 TriLink Biotechnologies Recent Development
11.13 Bio-Synthesis
11.13.1 Bio-Synthesis Company Details
11.13.2 Bio-Synthesis Business Overview
11.13.3 Bio-Synthesis Oligonucleotide Synthesis Introduction
11.13.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.13.5 Bio-Synthesis Recent Development
11.14 ATDBio
11.14.1 ATDBio Company Details
11.14.2 ATDBio Business Overview
11.14.3 ATDBio Oligonucleotide Synthesis Introduction
11.14.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2016-2021)
11.14.5 ATDBio Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Custom Oligonucleotides
Table 3. Key Players of Pre-designed Oligonucleotides
Table 4. Global Oligonucleotide Synthesis Market Size Growth by End User (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Oligonucleotide Synthesis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oligonucleotide Synthesis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Oligonucleotide Synthesis Market Share by Regions (2016-2021)
Table 8. Global Oligonucleotide Synthesis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Oligonucleotide Synthesis Market Share by Regions (2022-2027)
Table 10. Oligonucleotide Synthesis Market Trends
Table 11. Oligonucleotide Synthesis Market Drivers
Table 12. Oligonucleotide Synthesis Market Challenges
Table 13. Oligonucleotide Synthesis Market Restraints
Table 14. Global Oligonucleotide Synthesis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Oligonucleotide Synthesis Market Share by Players (2016-2021)
Table 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2020)
Table 17. Ranking of Global Top Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oligonucleotide Synthesis Product Solution and Service
Table 21. Date of Enter into Oligonucleotide Synthesis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Oligonucleotide Synthesis Revenue Market Share by Type (2016-2021)
Table 25. Global Oligonucleotide Synthesis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Oligonucleotide Synthesis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Oligonucleotide Synthesis Market Size Share by End User (2016-2021) & (US$ Million)
Table 28. Global Oligonucleotide Synthesis Revenue Market Share by End User (2016-2021)
Table 29. Global Oligonucleotide Synthesis Forecasted Market Size by End User (2022-2027) (US$ Million)
Table 30. Global Oligonucleotide Synthesis Revenue Market Share by End User (2022-2027) & (US$ Million)
Table 31. North America Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
Table 34. North America Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
Table 35. North America Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
Table 40. Europe Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
Table 41. Europe Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
Table 52. Latin America Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
Table 53. Latin America Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Integrated DNA Technologies Company Details
Table 62. Integrated DNA Technologies Business Overview
Table 63. Integrated DNA Technologies Oligonucleotide Synthesis Product
Table 64. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 65. Integrated DNA Technologies Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Oligonucleotide Synthesis Product
Table 69. Merck Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Eurofins Genomics Company Details
Table 72. Eurofins Genomics Business Overview
Table 73. Eurofins Genomics Oligonucleotide Synthesis Product
Table 74. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 75. Eurofins Genomics Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Oligonucleotide Synthesis Product
Table 79. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Oligonucleotide Synthesis Product
Table 84. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Eurogentec Company Details
Table 87. Eurogentec Business Overview
Table 88. Eurogentec Oligonucleotide Synthesis Product
Table 89. Eurogentec Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 90. Eurogentec Recent Development
Table 91. GE Healthcare Company Details
Table 92. GE Healthcare Business Overview
Table 93. GE Healthcare Oligonucleotide Synthesis Product
Table 94. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 95. GE Healthcare Recent Development
Table 96. LGC Biosearch Technologies Company Details
Table 97. LGC Biosearch Technologies Business Overview
Table 98. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 99. LGC Biosearch Technologies Recent Development
Table 100. Nitto Denko Avecia Company Details
Table 101. Nitto Denko Avecia Business Overview
Table 102. Nitto Denko Avecia Oligonucleotide Synthesis Product
Table 103. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 104. Nitto Denko Avecia Recent Development
Table 105. Genscript Company Details
Table 106. Genscript Business Overview
Table 107. Genscript Oligonucleotide Synthesis Product
Table 108. Genscript Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 109. Genscript Recent Development
Table 110. Genedesign Company Details
Table 111. Genedesign Business Overview
Table 112. Genedesign Oligonucleotide Synthesis Product
Table 113. Genedesign Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 114. Genedesign Recent Development
Table 115. TriLink Biotechnologies Company Details
Table 116. TriLink Biotechnologies Business Overview
Table 117. TriLink Biotechnologies Oligonucleotide Synthesis Product
Table 118. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 119. TriLink Biotechnologies Recent Development
Table 120. Bio-Synthesis Company Details
Table 121. Bio-Synthesis Business Overview
Table 122. Bio-Synthesis Oligonucleotide Synthesis Product
Table 123. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 124. Bio-Synthesis Recent Development
Table 125. ATDBio Company Details
Table 126. ATDBio Business Overview
Table 127. ATDBio Oligonucleotide Synthesis Product
Table 128. ATDBio Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
Table 129. ATDBio Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oligonucleotide Synthesis Market Share by Type: 2020 VS 2027
Figure 2. Custom Oligonucleotides Features
Figure 3. Pre-designed Oligonucleotides Features
Figure 4. Global Oligonucleotide Synthesis Market Share by End User: 2020 VS 2027
Figure 5. Academic Research Institutes Case Studies
Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Others Case Studies
Figure 9. Oligonucleotide Synthesis Report Years Considered
Figure 10. Global Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Oligonucleotide Synthesis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oligonucleotide Synthesis Market Share by Regions: 2020 VS 2027
Figure 13. Global Oligonucleotide Synthesis Market Share by Regions (2022-2027)
Figure 14. Global Oligonucleotide Synthesis Market Share by Players in 2020
Figure 15. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2020
Figure 17. Global Oligonucleotide Synthesis Revenue Market Share by Type (2016-2021)
Figure 18. Global Oligonucleotide Synthesis Revenue Market Share by Type (2022-2027)
Figure 19. North America Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Oligonucleotide Synthesis Market Share by Type (2016-2027)
Figure 21. North America Oligonucleotide Synthesis Market Share by End User (2016-2027)
Figure 22. North America Oligonucleotide Synthesis Market Share by Country (2016-2027)
Figure 23. United States Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oligonucleotide Synthesis Market Share by Type (2016-2027)
Figure 27. Europe Oligonucleotide Synthesis Market Share by End User (2016-2027)
Figure 28. Europe Oligonucleotide Synthesis Market Share by Country (2016-2027)
Figure 29. Germany Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oligonucleotide Synthesis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Oligonucleotide Synthesis Market Share by End User (2016-2027)
Figure 38. Asia-Pacific Oligonucleotide Synthesis Market Share by Region (2016-2027)
Figure 39. China Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oligonucleotide Synthesis Market Share by Type (2016-2027)
Figure 47. Latin America Oligonucleotide Synthesis Market Share by End User (2016-2027)
Figure 48. Latin America Oligonucleotide Synthesis Market Share by Country (2016-2027)
Figure 49. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oligonucleotide Synthesis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Oligonucleotide Synthesis Market Share by End User (2016-2027)
Figure 54. Middle East & Africa Oligonucleotide Synthesis Market Share by Country (2016-2027)
Figure 55. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 60. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 62. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 63. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 64. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 65. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 66. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 67. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 68. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 69. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 70. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 71. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のオリゴヌクレオチド合成市場規模・現状・予測（2021年-2027年） Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the de…- 世界のオリゴヌクレオチド市場規模・現状・予測（2021年-2027年） Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics. Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of…
- 世界のcDNA合成市場規模・現状・予測（2021年-2027年） Complementary DNA (cDNA) Synthesis has various application in bioinformatics as well as in genetics. cDNA is double-stranded DNA synthesized from a single stranded RNA. cDNA is mostly used for cloning eukaryotic genes in prokaryotes. It is used for transferring the cDNA which is used to code the pro…
- 世界のオリゴヌクレオチド治療薬市場規模・現状・予測（2021年-2027年） Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies. Although several types of oligonucleotide therapies exist, five of them a…
- 世界のオリゴヌクレオチドプール市場規模・現状・予測（2021年-2027年） Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with a…